Electromagnetic (EM) hyperthermic technologies hold great potential in the treatment of diseases, especially for cancers that are resistant to standard regimens. These technologies modify tissue temperature: hyperthermia heats the diseased tissue to make it susceptible to treatments, and ablation heats the tissue until it is destroyed. Hyperthermia is particularly effective in treatment of cervical and breast cancer, head and neck cancers, sarcoma in adults, and germ cell tumours in children; while radiofrequency and microwave ablation offer promise for treating liver, kidney, and lung cancers.
Working Group 1
This group will focus on fundamental dielectric and thermal research of biological tissues, with two main Focus Areas (FAs): creating…
Working Group 2
This group works on three focus areas: optimising the technology for existing thermal-based EM applications and developing ideas for novel…
Working Group 3
This group supports the commercial translation of EM therapeutic technologies through two focus areas: provide and support training on clinical…